RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

J Natl Cancer Inst. 2018 Oct 1;110(10):1142-1143. doi: 10.1093/jnci/djy029.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval*
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents